INTRODUCTION
In functional single ventricle or univentricular hearts, one of the two cardiac ventricles may be underdeveloped or may not function normally due to lack of a normal atrioventricular valve (Fig. 1 ). An uncorrected single ventricle has a parallel relationship with the right-to-left shunt, causing cyanosis and volume overload and leading to heart failure. The Fontan operation is a palliative surgical procedure performed in patients with single ventricle to divert the venous flow from the superior and inferior venae cavae to the pulmonary arteries without passage through a pumping ventricle. The most common congenital cardiac abnormalities palliated with the Fontan procedure are tricuspid atresia ( Fig. 1) , hypoplastic left heart syndrome, pulmonary atresia with an intact ventricular septum, and double-inlet ventricle.
In 1971, Francois Fontan and colleagues proposed a surgical technique as a palliative procedure for tricuspid atresia. They initially used a classical Glenn shunt, forming a connection between the superior vena cava (SVC) and the right pulmonary artery with ligation of the SVC-right atrial junction. In addition to this, a connection between the right atrium and the left pulmonary artery was created with an aortic homograft [1] . The Fontan procedure has undergone diverse modifications in order to improve patient outcomes (Fig. 2) . In recent years, the lateral tunnel or the extracardiac Fontan operation have become the most commonly used modified methods to direct blood from the systemic venous system to pulmonary circulation.
Due to increased survival rates with the use of advanced surgical techniques, long-term complications of the Fontan circulation are more commonly observed. Imaging follow-up and diagnosis of these complications are essential for early detection and treatment. In this article, we review the normal anatomy of common variations of the Fontan pathway, various multidetector computed tomography (MDCT) and cardiac magnetic resonance imaging (CMR) techniques for optimal imaging diagnosis of the Fontan pathway, and various spectra of imaging findings regarding potential complications in patients with failing Fontan. (Fig. 2) In the classic Fontan procedure, the right atrium or the right atrial appendage is directly connected to the pulmonary arteries, collectively termed an atriopulmonary connection (Figs. 2A cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The Fontan pathway is the result of a palliative surgical procedure achieved by direct anastomosis of systemic veins to the pulmonary arteries, bypassing a ventricle. It is performed in patients with functional univentricular heart physiology in which biventricular repair is not possible. Advances in surgical techniques with modified Fontan procedures have led to improved long-term results and increased life expectancy in such patients. Consequently, late complications of the Fontan procedure are being increasingly encountered, particularly in patients with poor hemodynamics. Accordingly, radiologists are increasingly likely to encounter longterm complications of the Fontan pathway in certain cardiac patients. The purpose of this article is to familiarize radiologists with the surgical techniques of the Fontan procedure, to describe the technical considerations for optimal image acquisition and the expected normal postoperative anatomy, and to illustrate the imaging findings of postoperative complications in these patients.
ANATOMY OF THE FONTAN PROCEDURE
Imaging of the Fontan Pathway CVIA and 3). This method was predominantly used up to the late 1980s. However, it is now understood that, as a consequence of this method, significant right atrial dilatation can result in atrial arrhythmias and atrial thrombus formation [2, 3] . As a result, the classic Fontan procedure is no longer employed, and it has been replaced by the more energy efficient lateral tunnel (Fig.  2B ) or extracardiac Fontan procedure (Fig. 2C ). This total cavopulmonary connection comprises a variety of cavopulmonary connections including the bidirectional cavopulmonary shunt (BCPS), the lateral tunnel, and the extracardiac conduit [4, 5] . The BCPS is performed to redirect SVC flow to the pulmonary circulation, bypassing the right heart by end-to-side anastomosis of the SVC to the right pulmonary artery after division of the superior cavo-atrial junction (Fig. 4) . The main pulmonary artery is typically divided to completely bypass the right heart. The BCPS is performed as a permanent palliative procedure, an intermediate procedure of a staged Fontan operation (Fig. 4) , or a component of the primary Fontan operation (Figs. 5, 6 , and 7).
Total cavopulmonary connection is completed by redirecting inferior vena cava (IVC) flow to the pulmonary circulation using an intra-arterial lateral tunnel or an extracardiac conduit. In the lateral tunnel method (Figs. 2B, 5, and 6), a lateral tunnel is formed by an intra-atrial tunnel-like baffle using both the lateral wall of the right atrium and a prosthetic patch. The superior aspect of the lateral tunnel is anastomosed to the inferior wall of the pulmonary artery, and the inferior aspect of the lat- In heterotaxy patients with IVC interruption and azygos continuation, the SVC incorporates most (85%) of the systemic venous flow into the heart, with the exception of the venous flow from the coronary sinus and the hepatic vein. In such patients, the cavopulmonary connection of the SVC distal to the drainage of the azygos vein to the pulmonary artery is called the Kawashima operation (Fig. 2D) . Exclusion of the hepatic venous blood from the pulmonary circulation is a major risk factor for pulmonary arteriovenous malformation (PAVM). To prevent or to alleviate PAVM, hepatic veins should be incorporated into pulmonary circulation using the Fontan procedure (Fig. 8) , or a graft should be interposed between the hepatic vein and the azygos vein.
In high-risk patients, fenestration can be created between the Fontan pathway and the atrium using a window at the lateral tunnel or a tube graft on the extracardiac conduit. This fenestration can reduce early morbidity by shunting the blood from the Fontan pathway to the atrium when systemic venous pressure is elevated in the early postoperative period (Fig. 9 ) [6] . 
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IMAGING CONSIDERATIONS FOR THE FONTAN PROCEDURE Computed tomography
As in other congenital heart diseases, echocardiography plays a primary and definitive role in imaging of the Fontan procedure. However, echocardiography is often non-diagnostic due to a limited acoustic window, particularly in adult survivors, as well as to shadowing caused by surgical clips, stents, baffles, and conduits. Echocardiography is often insufficient to adequately assess the Fontan pathway and the pulmonary artery. CMR is a useful complementary tool for follow-up in patients who undergo the Fontan procedure in order to demonstrate morphologic abnormalities and to assess functional complications.
However, CMR is still contraindicated in patients with pacemakers and defibrillators and is not able to provide suitable image quality in patients with susceptibility artifacts due to surgical materials such as hemostatic clips, stents, and embolization coils.
MDCT has been increasingly used in the morphologic evaluation of extracardiac vasculature in congenital heart disease with the development of a faster scanner to improve temporal resolution with a decrease in cardiac motion artifacts, higher spatial resolution, isotropic reformatted images in any plane, and reduction of the radiation dose. When echocardiography and CMR provide insufficient information or when CMR is contraindicated in patients with the Fontan pathway, MDCT angiography is utilized as an alternative imaging modality to detect 
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Imaging of the Fontan Pathway CVIA complications such as thrombosis, stenosis, pulmonary embolism, pulmonary arteriovenous fistula, arterial collaterals, and venous collaterals. Using electrocardiogram (ECG) triggering or ECG gating, MDCT scans can also be utilized to evaluate intracardiac morphology and systolic function.
Diagnostic pitfall in MDCT scans: "Streaming artifact"
In patients who undergo the Fontan procedure, successful computerized tomography (CT) scanning requires optimal and uniform simultaneous contrast enhancement of the Fontan pathway and pulmonary arteries. Differential timing of opacification of the superior and inferior venae cavae, incomplete mixing in the Fontan circuit, and differential streaming of contrast into pulmonary arteries result in inhomogeneous opacification of the Fontan pathway. Therefore, proper selection of injection sites, timing of contrast administration, and initiation of scanning are critically important. Because the Fontan circuit drains two different systemic venous sources, and because Fontan circulation flow is characterized as passive laminar flow, homogeneous enhancement of the Fontan pathway cannot be obtained until the venous phase. If the acquisition of CT scans is routinely initiated before the venous phase, then the incompletely opacified blood can be either non-diagnostic or misdiagnosed as thromboembolism (Fig. 10) [7] .
CT techniques for Fontan circulation
To mitigate the streaming artifact of the Fontan pathway, various enhancement protocols have been established, including dual injection techniques, delayed imaging, and bolus tracking methods.
Dual injection protocol is a method involving simultaneous injection of iodinated contrast through both upper and lower extremities, which allows denser opacification of the entire Fontan circuit. Greenberg and Bhutta [8] 
Another option is delayed scanning when the venous blood returns to the Fontan pathway following systemic circulation. A one-minute-delayed scan usually provides adequate contrast opacification of the intrathoracic vasculature with only minor inhomogeneity. In patients with an atriopulmonary Fontan connection, significant ventricular dysfunction, or severe atrioventricular valve regurgitation, scans should be acquired even after one minute due to slow circulation. The three-minute-delayed scan provides the most homogeneous contrast opacification for the detection of a thrombus in the Fontan pathway. However, overall reduction of contrast density can make image interpretation difficult, particularly if low-radiation dose protocols are Fig. 10 . A 14-year-old female who underwent extracardiac Fontan operation for complete AVSD. Transverse (A) and oblique sagittal (B) reformatted images acquired in the early venous phase show a streaming artifact mimicking thrombosis. The venous delayed phase was scanned too early, at about a 40 second delay, and the streaming artifact is still seen in the Fontan conduit. Note thick circumferential calcification of the conduit (arrows).
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Sun Hwa Hong, et al CVIA used (Fig. 11 ) [10] . An early arterial phase scan is needed for detection of aortopulmonary collateral (APC), which can be a source of lifethreatening hemoptysis (Fig. 12) . The bolus tracking method is considered the most effective method to initiate arterial phase CT scanning because of the unpredictable degree of contrast enhancement secondary to variable blood flow velocity in the Fontan pathway and the pulmonary artery [11] .
Magnetic resonance imaging
When echocardiography is not feasible and is non-diagnostic, CMR can play a complementary role in obtaining comprehensive anatomical and functional information, particularly in older patients who have undergone the Fontan procedure. CMR can evaluate morphologic abnormalities, including the Fontan conduit, systemic veins, pulmonary arteries and veins, and collaterals. To evaluate any structural abnormality following the Fontan procedure, black blood spin-echo imaging and contrastenhanced magnetic resonance angiography (MRA) are used. CMR readily provides functional parameters using flowmetry and volumetry to quantify valvular regurgitation, pulmonary and systemic blood flow, and APCs [6, 12] , which cannot be obtained by MDCT. Magnetic resonance imaging (MRI) evaluation is limited in patients with surgical or interventional ferromagnetic materials, which cause large susceptibility artifacts.
To obtain functional information, cine steady-state free-precession (SSFP) imaging and phase-contrast velocity-encoded cine imaging are typically used (Fig. 13) [13] .
Cine SSFP imaging is used to obtain functional parameters, such as ventricular volume and ejection fraction, using volumetry. These MR parameters are thought to be the reference standard for the assessment of ventricular function, and they are clinically important for follow-up in patients who have received the Fontan procedure.
Phase-contrast velocity-encoded imaging allows accurate flowmetry for quantitative evaluation of valvular regurgitation, pulmonary to systemic blood flow ratio (Qp/Qs), and burden of collateral flow. The Qp/Qs ratio is usually calculated across the main pulmonary artery and the ascending aorta by phase-contrast imaging, which provides important information about the presence and degree of right-to-left shunts, systemic to pulmonary venous shunts, or baffle leak. CMR also allows calculation of APC blood flow [14] .
Late gadolinium enhancement (LGE) CMR is utilized to detect myocardial fibrosis and infarction. An increased extent of LGE was associated with a lower ejection fraction, increased CMR-derived ventricular end-diastolic volume index and mass index, and non-sustained ventricular tachycardia [15] . Contrast-enhanced MRA is used for the identification of collateral vessels and extracardiac vascular anatomy.
ABNORMAL IMAGING FEATURES OF THE FONTAN PATHWAY
Many patients who undergo the Fontan procedure have substantially prolonged survival and improved quality of life in comparison to those who undergo only shunt operation. Due to the prolonged survival of these patients with abnormal palliative physiology, however, late complications are being increasingly observed in children and young adults. Commonly encountered cardiac and extracardiac complications include Fontan conduit stenosis and thrombosis, SVC stenosis, peripheral pulmonary artery stenosis, right atrium dilatation and arrhythmia, pulmonary embolism, systemic venous collateralization, PAVMs, hepatic problems, and lymphatic dysfunction [3, 13, 16] . 
A B C
Imaging of the Fontan Pathway
CVIA
Conduit stenosis
Stenosis of the conduit usually occurs at the site of anastomosis with the pulmonary artery, and conduit problems include pseudointimal peel, thrombosis, calcification, or a small conduit relative to the physical growth of the patient. Such stenosis is a potential complication of the Fontan procedure, which causes severe symptoms of systemic venous obstruction and requires stenting or surgical replacement. MDCT can provide excellent information about the presence of conduit stenosis, along with its cause and degree (Figs. 14 and 15) . Using three-dimensional volume rendering and multiplanar reformatted MDCT images, the diameters of the Fontan conduit and branch pulmonary arteries should be analyzed.
Thrombosis
Pulmonary embolism is a life-threatening thromboembolic complication of Fontan circulation due to stasis and slow flow. In this situation, Fontan circulation has an imbalance between procoagulant and anticoagulant factors [17] . High mortality from thromboembolic events is also related to arrhythmia as a result of increased atrial pressure and distention, particularly in atriopulmonary Fontan procedures. The reported incidence of postoperative thromboembolic disease varies from 3% to 19% [9, [18] [19] [20] . Moreover, a recent retrospective study of asymptomatic patients with Fontan circulation reported that 13% had a mural thrombus within the extracardiac conduit [21] .
On MDCT, low-density thickening within the Fontan conduit suggests conduit thrombosis and a central filling defect surrounded by homogeneous IV contrast material, which suggests pulmonary thromboembolism (Fig. 16) . CMR also provides excellent anatomic information on atrial dilatation and the presence of a thrombus. Differentiating the thrombus from any "swirl- Sun Hwa Hong, et al CVIA ing artifacts" of a Fontan conduit is potentially difficult on both MDCT and CMR. A thrombus is most reliably identified using delayed MDCT scanning in the venous phase and contrast-enhanced MRA [16] .
Pulmonary arteriovenous malformation
Although the etiology of PAVM remains unclear, the absence of pulsatile blood flow, underfilling of the pulmonary arteries, and the relative lack or asymmetrical distribution of hepatic venous blood to the pulmonary circulation appear to be possible factors (Fig. 17) . Also, the Fontan conduit is thrombogenic because of venous stasis and low passive flow. It has been postulated that a hepatic factor exists, and that it prevents the opening of arteriovenous communications. Bernstein et al. [22] reported that 60% of patients with a cavopulmonary shunt developed PAVM. Heterotaxy patients with left isomerism, interrupted IVC, and azygos continuation who underwent the Kawashima operation showed an increased incidence of PAVM relative to those who underwent the Fontan operation (Fig. 18) . In patients who undergo the Kawashima operation, the IVC drains through an azygos vein into the SVC. Accordingly, only hepatic veins drain into systemic circulation, thereby bypassing pulmonary vasculature. On MDCT, abnormally enlarged pulmonary vessels, which form a small tangle of vessels extending 
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Imaging of the Fontan Pathway CVIA to the periphery of the lung, suggest PAVM [23] . Both MDCT and contrast-enhanced MRA can accurately demonstrate PAVM [24] .
Systemic-pulmonary venovenous shunts (venous collaterals)
Venovenous collaterals from the systemic vein to the pulmonary vein are frequent in patients who undergo the Fontan operation as a consequence of elevated central venous pressure. Desaturation by right-to-left shunts through venovenous collaterals may cause cyanosis. When cyanosis is significant, venovenous collaterals are embolized using an embolization coil or a vascular plug.
MDCT is able to demonstrate venovenous collaterals, especially in the early arterial phase (Fig. 19 ) [23] . 
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Aortopulmonary collaterals (arterial collaterals)
In patients who undergo the palliative Fontan procedure, development of APCs is frequently observed due to arterial hypoxemia. Eventually, APCs result in left-to-right shunts (Fig. 12) . APCs usually arise from the descending aorta, subclavian artery branches, and bronchial and intercostal arteries. With the passage of time, APCs result in left-to-right shunts and increased pulmonary blood flow and pressure. APCs have many physiologic implications, such as ventricular volume overload and pleural effusion. In addition, APCs can be a source of life-threatening hemoptysis in close association with bronchial tree dilatation, airway erosion, and rupture. MDCT depicts the locations of APCs, and CMR allows estimation of APC blood flow. Grosse-Wortmann et al. [14] reported two methods for calculating APC blood flow. Method A involved summation of the individual pulmonary vein flows. Subsequently, the sum of the 
Cardiac cirrhosis and hepatic nodules
Chronically elevated systemic venous pressure associated with Fontan circulation causes increased retrograde pressure in the hepatic sinusoids. This may lead to passive hepatic congestion, hepatic cirrhosis, and portal hypertension, which can be complicated by dysplastic nodules and hepatocellular carcinoma. Because children are often asymptomatic, congestive hepatopathy is usually first detected on MDCT and CMR imaging. Congestive hepatopathy manifests in inhomogeneous reticular enhancement patterns, most prominent in the periphery of the liver, which are best observed in the portal venous phase. Chronic passive hepatic venous congestion can also lead to the formation of venovenous collaterals.
A chronic increase in hepatic venous pressure results in arterialization of hepatic flow, which can lead to the development of hypervascular dysplastic nodules. These benign regenerative or focal nodular hyperplasia-like nodules are typically isodense to liver on precontrast images, show avid enhancement in the arterial phase, and are slightly hyperdense/isodense to liver parenchyma in the portal and equilibrium phases of MDCT (Fig.  20) . Also, they show intense enhancement in the arterial phase and are slightly hyperintense/isointense to liver parenchyma in the portal and equilibrium phases of MRI [23] .
Protein-losing enteropathy
Elevated lymphatic pressure may result in lymphedema, pulmonary edema, and pleural and pericardial effusion. Ascites and protein-losing enteropathy are additional late but serious abdominal complications of Fontan circulation.
Protein-losing enteropathy is a rare manifestation of failing Fontan circulation. Although its etiology is not clearly established, enteric protein loss may be due to systemic venous hypertension that is transmitted to the hepatic circulation. Even though protein-losing enteropathy does not manifest specific CT and MRI imaging findings, it should be suspected in patients with abdominal pain, diarrhea, recurrent pleural effusion and ascites, hypoproteinemia, hypocalcemia, and coagulopathy [25] .
CONCLUSION
In patients who undergo the Fontan procedure, postoperative imaging follow-up with CMR and MDCT is essential for early detection of cardiac and extracardiac complications. Special modifications to the imaging protocols for these patients are required to optimally evaluate the Fontan pathway. Radiologists should be familiar with the varying types of Fontan pathways, the imaging techniques, and the diverse imaging features of abnormal postsurgical complications, including thromboembolism, stenosis of the conduit, pulmonary artery stenosis, arterial and venous collaterals, PAVM, hepatic congestion, and cardiac cirrhosis. A B C
